Comparison of prostate cancer detection rate at targeted biopsy of hub and spoke centers mpMRI: experience matters-Reference-Cited by-同舟云学术

Comparison of prostate cancer detection rate at targeted biopsy of hub and spoke centers mpMRI: experience matters

Published:2023-02 Issue:1 Volume:75 Page:
ISSN:2724-6051
Container-title:Minerva Urology and Nephrology
language:
Short-container-title:Minerva Urol Nephrol

Author:

DROGHETTI Matteo,BIANCHI Lorenzo,GAUDIANO Caterina,CORCIONI Beniamino,RUSTICI Arianna,PIAZZA Pietro,BERETTA Carlo,BALESTRAZZI Eleonora,COSTA Francesco,FERUZZI Alberto,SALVADOR Marco,GIUNCHI Francesca,FIORENTINO Michelangelo,GOLFIERI Rita,SCHIAVINA Riccardo,BRUNOCILLA Eugenio

Publisher

Edizioni Minerva Medica

Subject

Urology,Nephrology

Link

https://www.minervamedica.it/pdf.php?cod=R19Y2023N01A0042

Reference25 articles.

1. Mottet N, van den Bergh RC, Briers E, Cornford P, De Santis M, Fanti S, et al. EAU - ESTRO - ESUR - SIOG Guidelines on Prostate Cancer 2020. In: European Association of Urology Guidelines 2020 Edition. Arnhem, The Netherlands: European Association of Urology Guidelines Office; 2020 [Internet]. Available from: http://uroweb.org/guideline/prostate-cancer/ [cited 2022, Jun 23].

2. MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis

3. Magnetic Resonance Imaging-targeted Biopsy Versus Systematic Biopsy in the Detection of Prostate Cancer: A Systematic Review and Meta-analysis

4. Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study

5. Is There Still a Need for Repeated Systematic Biopsies in Patients with Previous Negative Biopsies in the Era of Magnetic Resonance Imaging-targeted Biopsies of the Prostate?

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Update on PI-RADS Version 2.1 Diagnostic Performance Benchmarks for Prostate MRI: Systematic Review and Meta-Analysis;Radiology;2024-08-01

2. Urinary PSA-ZINC biomarker outperforms standard of care in early detection of prostate cancer;Minerva Urology and Nephrology;2024-06

3. Immunohistochemistry analysis of PSMA expression at prostatic biopsy in high-risk prostate cancer: potential implications for PSMA-PET patient selection;Frontiers in Oncology;2024-05-14

4. Creating a novel multiparametric magnetic resonance imaging-based biopsy strategy for reducing unnecessary prostate biopsies: a retrospective cohort study;Quantitative Imaging in Medicine and Surgery;2024-02

5. Diagnosis of prostate cancer with magnetic resonance imaging in men treated with 5-alpha-reductase inhibitors;World Journal of Urology;2023-10-03